ImmuPharma licenses lupus drug Lupuzor to Avion in the United States
LONDON (Reuters) – British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for Lupuzor, a first-in-class treatment for auto-immune disease Lupus, with U.S. company…